Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Walgreens Boots Alliance, Inc.
  6. Summary
    WBA   US9314271084

WALGREENS BOOTS ALLIANCE, INC.

(WBA)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/07/2021 06/08/2021 06/09/2021 06/10/2021 06/11/2021 Date
54.56(c) 54(c) 53.43(c) 55.31(c) 55.31(c) Last
3 026 098 3 800 312 5 257 350 6 638 021 3 934 881 Volume
-0.53% -1.03% -1.06% +3.52% 0.00% Change
More quotes
Financials (USD)
Sales 2021 132 B - -
Net income 2021 2 149 M - -
Net Debt 2021 8 803 M - -
P/E ratio 2021 19,8x
Yield 2021 3,46%
Sales 2022 136 B - -
Net income 2022 3 490 M - -
Net Debt 2022 6 913 M - -
P/E ratio 2022 13,3x
Yield 2022 3,56%
Capitalization 47 810 M 47 810 M -
EV / Sales 2021 0,43x
EV / Sales 2022 0,40x
Nbr of Employees 277 000
Free-Float 61,0%
More Financials
Company
Walgreens Boots Alliance, Inc., is a holding company. The Company is a pharmacy-led health and wellbeing company. The Company operates through three segments: Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Retail Pharmacy USA segment consists of the Walgreen Co. (Walgreens) business, which includes the operation of retail drugstores, care clinics and providing specialty pharmacy... 
Read more
Sector
Drug Retailers
Calendar
07/01 | 07:00amEarnings Release
More about the company
Ratings of Walgreens Boots Alliance, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about WALGREENS BOOTS ALLIANCE, INC.
06/10WALGREENS  : Continues to Boost COVID-19 Vaccination Access Across the Country
BU
06/10Walgreens Extending Pharmacy Hours to Give More Vaccine Flexibility
DJ
06/09Labcorp Launches COVID-19 At-Home Test Kit at Walgreens
MT
06/08Amazon Pharmacy offers half-yearly prescriptions starting at $6
RE
06/08ANALYST RECOMMENDATIONS : Amgen, Biogen, Halfords, J Sainsbury, Uber...
06/07CORRECTION : Mizuho Securities Maintains Price Target for Walgreens Boots Allian..
MT
06/07WALGREENS BOOTS ALLIANCE  : Mizuho Securities Adjusts Walgreens Boots Alliance P..
MT
06/04WALGREENS BOOTS ALLIANCE  : Company deploying proceeds of $6.5 billion to pay do..
PU
06/04WALGREENS BOOTS ALLIANCE, INC.  : Completion of Acquisition or Disposition of As..
AQ
06/03INSIDER TRENDS : Walgreens Boots Alliance Insider Makes Shares Sale for Tax Slow..
MT
06/03WALGREENS BOOTS ALLIANCE  : Schedules Fiscal 2021 Third Quarter Earnings Announc..
BU
06/02WALGREENS BOOTS ALLIANCE  : Sells Alliance Healthcare Businesses to AmerisourceB..
MT
06/02WALGREENS BOOTS ALLIANCE  : Completes Strategic Transaction with AmerisourceBerg..
BU
06/02AmerisourceBergen Boosts Fiscal Year Earnings Forecast
DJ
05/26Wall Street edges up with U.S. bond yields in check
RE
More news
News in other languages on WALGREENS BOOTS ALLIANCE, INC.
06/03TOP STORIES ITALIA  : Diasorin, nuovi test coerenti con strategia
06/03DIASORIN S P A  : accordi distribuzione in farmacie di piattaforma e test Liaiso..
06/03DIASORIN  : distribuira' nelle farmacie italiane 2 test Covid
05/31ANALYSE/Amazon und Walmart haben ein Rezept für das US-Gesundheitswesen
05/14USA : bas les masques dans certains magasins, après les nouvelles recommandation..
More news
Analyst Recommendations on WALGREENS BOOTS ALLIANCE, INC.
More recommendations
Analysis
Hedge funds bet on subscription-based businesses, pharmacy and copper
Chart WALGREENS BOOTS ALLIANCE, INC.
Duration : Period :
Walgreens Boots Alliance, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends WALGREENS BOOTS ALLIANCE, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 22
Average target price 55,39 $
Last Close Price 55,31 $
Spread / Highest target 30,2%
Spread / Average Target 0,14%
Spread / Lowest Target -24,1%
EPS Revisions
Managers and Directors
NameTitle
Rosalind Gates Brewer Chief Executive Officer & Director
James Kehoe Global Chief Financial Officer & Executive VP
Stefano Pessina Executive Chairman
Francesco Tinto Global Chief Information Officer & Senior VP
Ornella Barra Chief Operating Officer
Sector and Competitors
1st jan.Capitalization (M$)
WALGREENS BOOTS ALLIANCE, INC.38.69%47 810
JD HEALTH INTERNATIONAL INC.-27.87%44 398
MCKESSON CORPORATION12.41%30 237
CARDINAL HEALTH, INC.12.04%17 209
HUADONG MEDICINE CO., LTD80.27%13 094
SINOPHARM GROUP CO., LTD.37.86%10 455